Table 1. Utilization of PCI and in-hospital mortality in STEMI patients with and without cancer.
| Variables | Breast cancer (N=3,871) (%) | Lung cancer (N=22,480) (%) | Colon cancer (N=9,944) (%) | No cancer (N=2,990,913) (%) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PCI | No PCI | PCI | No PCI | PCI | No PCI | PCI | No PCI | ||||
| No. of patients | 1,191 (30.8) | 2,680 (69.2) | 4,541 (20.2) | 17,939 (79.8) | 1,716 (17.3) | 8,228 (82.7) | 1,483,706 (49.6) | 1,507,207 (50.4) | |||
| In-hospital mortality | 90 (7.6) | 747* (27.9) | 698 (15.4) | 7,484* (41.7) | 178 (10.4) | 2,693* (32.7) | 58,037 (3.9) | 328,762* (21.8) | |||
*, represents that there is a statistically significant difference in mortality between the PCI and no PCI groups with a P value of <0.001. PCI, percutaneous coronary intervention; STEMI, ST-elevation myocardial infarction.